Contact PDDA® Studio

Tell Me What You Need to Improve

A clinic conversion problem, a product adoption challenge or a new launch. Start with the change you want—not the name of a service.

One Short Note Is Enough

Send me the problem as you see it. I reply personally within two working days. If there is a fit, I will suggest times for a 20-minute introductory call.

We will clarify the result you want, what you have already tried and whether a focused project makes sense. If it does, I will outline the next step. Detailed diagnosis and implementation are scoped separately.

Typical clinic questions

Why does the premium conversation change between the website, coordinator and surgeon? Are eligible patients consistently reaching and understanding their options? What should the clinic measure before and after changing the pathway?

Typical brand questions

Where does product differentiation become a generic feature list? Does the patient language work in a specific market? What should a clinic pilot prove before the programme is scaled?

Based in Alicante, Spain · Remote across markets · On-site across Europe · English, Ukrainian and Russian

Prefer email? oleksii@pddastudio.com

Please do not include patient-identifiable or confidential clinical information.0 / 1500
How your information is used

Oleksii Sologub, trading as PDDA® Studio, is the controller of the information submitted here. It is used only to respond to your request, take relevant pre-contractual steps and manage any resulting business relationship. It is delivered to the PDDA® Studio business inbox, not added to a marketing list, and retained only while needed for those purposes or applicable legal obligations. To request access, correction or deletion, email oleksii@pddastudio.com.

Do not submit patient-identifiable information. Clinic measurement work uses aggregated or de-identified operational data, while the clinic retains control of patient data.

I reply personally within two working days. No patient data or confidential material is needed at this stage.